LATERAL NECK DISSECTION 4 th post-grad course in Endocrine Surgery 2012
|
|
- Patrick Bell
- 7 years ago
- Views:
Transcription
1 LATERAL NECK DISSECTION 4 th post-grad course in Endocrine Surgery 2012 MAURICE STEVENS ( ENT, Head and Neck ) ROYAL BRISBANE AND WOMENS HOSPITAL Head and Neck Multidiciplinary Clinic
2 PAPILLARY THYROID CANCER FNA suspicious thyroid lumps 50-75% are malignant Metastatic disease at presentation 25-64% - not a potent adverse indicator of prog. - higher chance of locoregional recurr. - clinical incidence of recurr. is no> 10-20% when the neck is not surgically treated WHY? TSH suppress - RAI - fail to grow
3 PAPILLARY THYROID CANCER prognostic factors Tumour size Extrathyroidal spread Angiolymphatic invasion Multifocal Any positive lymph nodes BRAF mutation - more aggressive!
4 PAPILLARY THYROID CANCER Presence of LN mets. does affect prognosis The days of cherry picking are over Elective dissection in a clin./radiol. Neg. neck is highly controversial Post- op RAI is not always preferred ( Japan ) or available FDG avid disease tends to be resistant to RAI
5 PAPILLARY THYROID CANCER Lymphatic Spread High incidence if Primary > 1 cm 90 % of pts. with lateral mets. have central mets. First echelon nodes are central nodes Second echelon nodes are lateral nodes???? always
6 PAPILLARY THYROID CANCER Pattern of central spread 45% of unilateral tumours >1cm cm. 40% to paratracheal-24% to pretracheal 10% contralateral central 17% contralateral occult
7 PAPILLARY THYROID CANCER Lateral cervical spread Second echelon nodes Levels 11 to Vb Levels 11 to 1V - account for 75% mets. Levels 111 /1V most common Level 1-4% mets. ( mostly 1b ) Level Vb 16% Suboccipital and Va rare Skip lesions 8% - explanation? Occult mets %
8 WHEN TO DISSECT THE NECK Elective lateral rarely - if clin./ radiol positive nodes only Elective central - dependent on - tumour size - risk factors Of no survival advantage if micropapillary
9 REGIONAL RECURRENCE Overall 5-10% Highest in first 3 years 50% in first 12 months Very few after 5 years
10 MICROPAPILLARY THYROID CANCER If total thyroidectomy and elective neck dissection occult nodes in - central 60% - lateral 40% Rate of LN recurrence <1% - whether there is neck dissection or not -?why If total thyroidectomy and no neck dissection - most LN recurrences are ipsilateral - in levels 1V,111,11 in descending order
11 MEDULLARY THYROID CANCER Management of the neck is surgical alone Early detection > better survival Surgery is the only means of cure Distant spread common Survival related to resectability Therapeutic neck dissection only Elective neck dissection does not increase survival END ( lateral ) if tumour >1 cm or known central compartment disease
12 MICROMEDULLARY CANCER < 1 cm LN mets. at diagnosis up to 30% 1/3 multifocal Most intrathyroid >5% distant mets % have >10 positive nodes 8% paediatric Survival overall 90% at 10 years - 50% alive at 10 years with distant mets
13 MICROMEDULLARY THYROID CANCER Strongest predictor of LN mets. is- - Extrathyroidal spread - Tumour size Standard of care - - Total thyroidectomy - Central dissection - Lateral dissection if Clin./ radiol. pos. nodes
14 LYMPH NODE ANATOMY IN THE NECK 300 Lymph Nodes on each side 50 are accessible surgically Presence of surgically inaccessible nodes at presentation assoc. with poor prognosis Main risks- - Nerve injury - Chylous leaks
15 LEVELS OF THE NECK
16 SKIN INCISIONS A matter of choice Don t cross the midline if unilateral XRT likely Avoid junctions over the carotid Save the Great auricular n. and MMB of V11
17 POST OPERATION Skin closure Suction drains- removal at about 4-5 days Parenteral antibiotics General medical care? Physiotherapy
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing
More informationAdvances in Differentiated Thyroid Cancer
Advances in Differentiated Thyroid Cancer Steven A. De Jong, M.D., FACS, FACE Professor and Vice Chair Clinical Affairs Department of Surgery Loyola University Medical Center Thyroid Cancer classification
More informationSurgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科
Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Papillary microcarcinoma of thyroid Definition latent aberrant thyroid occult thyroid carcinoma latent papillary carcinoma)
More informationTHYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
More informationSUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
More informationUpdate on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery
Update on thyroid cancer surveillance and management of recurrent disease Minimally invasive thyroid surgery July 2006 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor, David
More informationThyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)
Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules) Jeffrey S. Freeman, D.O., F.A.C.O.I. Chairman, Division of Endocrinology and Metabolism Philadelphia College
More informationThyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD
Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence Cord Sturgeon, MD Associate Professor of Surgery Northwestern University Feinberg School of Medicine Director of Endocrine Surgery Chicago,
More informationRecurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve,
Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve, Larynx, Trachea, & Esophageal Management Robert C. Wang,
More informationThyroid and Adrenal Gland
Thyroid and Adrenal Gland NAACCR 2011 2012 Webinar Series 12/1/11 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationThyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010
Thyroid Cancer Diagnosis and Management Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010 DISCLOSURE NOTHING TO DISCLOSE in regard to financial conflict
More informationTNM Staging of Head and Neck Cancer and Neck Dissection Classification
QUICK REFERENCE GUIDE TO TNM Staging of Head and Neck Cancer and Neck Dissection Classification Fourth Edition 2014 All materials in this ebook are copyrighted by the American Academy of Otolaryngology
More informationStaging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual
Staging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual Jatin P. Shah, MD, PhD (Hon) Memorial Sloan-Kettering Cancer Center New York, New York The American
More informationIl percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Maria Chiara Zatelli Sezione di Endocrinologia Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università
More informationLatest Oncologic Strategies for Well-Differentiated Thyroid Carcinoma
Latest Oncologic Strategies for Well-Differentiated Thyroid Carcinoma April 2008 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor of Surgery and Medicine David Geffen School of
More informationThe recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).
INTRODUCTION This book has been prepared for people with bowel cancer, their families and friends. The first section is for people with bowel cancer, and is intended to help you understand what bowel cancer
More information<1 cm WDT-UMP, FT-UMP. Kakudo K et al, Pathol Int,2009, Endocr J, 2011 and Pathol Int, 2012
More information
Hemithyroidectomy increases the risk of disease recurrence in patients with ipsilateral multifocal papillary thyroid carcinoma
1412 Hemithyroidectomy increases the risk of disease recurrence in patients with ipsilateral multifocal papillary thyroid carcinoma XIAOLONG LI 1*, CUI ZHAO 1*, DANDAN HU 1, YANG YU 1, JIN GAO 2, WENCHUAN
More informationThe epidemic of thyroid cancer and its evolving management: Is less more?
The epidemic of thyroid cancer and its evolving management: Is less more? Julie Ann Sosa, MD MA FACS Professor of Surgery and Medicine Chief, Section of Endocrine Surgery, and Leader, Endocrine Neoplasia
More informationBRAF as a prognostic marker in papillary thyroid cancer
12 Congresso Nazionale AME Molecular markers in thyroid cancer: current role in clinical practice BRAF as a prognostic marker in papillary thyroid cancer Dott. ssa Cristina Romei Sezione di Endocrinologia
More informationIV. DEFINITION OF LYMPH NODE GROUPS (FIGURE 1) Level IA: Submental Group
IV. DEFINITION OF LYMPH NODE GROUPS (FIGURE 1) Fig. 1 The level system is used for describing the location of lymph nodes in the neck: Level I, submental and submandibular group; Level II, upper jugular
More informationLocoregional recurrence or persistence of papillary carcinoma: radioiodine treatment
Locoregional recurrence or persistence of papillary carcinoma: radioiodine treatment Michele Klain, Marco Salvatore Department of Functional and Biomorphological Science University of Naples "Federico
More informationManagement of Differentiated Thyroid Carcinoma American Thyroid Association Guidelines and Data from Kaohsiung Chang Gung Memorial Hospital
Review Management of Differentiated Thyroid Carcinoma American Thyroid Association Guidelines and Data from Kaohsiung Chang Gung Memorial Hospital Pei-Wen Wang Abstract Background. Most thyroid cancers
More informationPrediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma
Clinical Endocrinology (2014) 81, 282 288 doi: 10.1111/cen.12417 ORIGINAL ARTICLE Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma Yinlong Yang*,, Chengze Chen,
More informationManagement of Well Differentiated Thyroid Cancers: Where We Have Been and Where We are Headed
Management of Well Differentiated Thyroid Cancers: Where We Have Been and Where We are Headed Medical Grand Rounds December 10,2015 Christine Signore, MD ECNU Learning Objectives Discuss the epidemiology
More informationFollowup of Patients with Papillary Thyroid Cancer: In Search of the Optimal Algorithm
Followup of Patients with Papillary Thyroid Cancer: In Search of the Optimal Algorithm Elizabeth A Mittendorf, MD, Xuemei Wang, MS, Nancy D Perrier, MD, Ashleigh M Francis, BSPH, Beth S Edeiken, MD, Suzanne
More informationBRAF in the diagnostic evaluation of thyroid nodules
Symposium 13 Molecular markers in thyroid cancer: current role in clinical practice BRAF in the diagnostic evaluation of thyroid nodules Laura Fugazzola University of Milan, Italy Papillary carcinoma BRAF
More informationWELL DIFFERENTIATED THYROID CANCER
Scandinavian Journal of Surgery 93: 261 271, 2004 WELL DIFFERENTIATED THYROID CANCER N. R. Caron, O. H. Clark Department of Surgery, University of California, San Francisco and UCSF Comprehensive Cancer
More informationRESEARCH COMMUNICATION
DOI:http://dx.doi.org/10.7314/APJCP.2012.13.4.1267 BRAF Mutation is Predictive of Occult Contralateral Carcinoma in Papillary Thyroid Microcarcinoma Cases RESEARCH COMMUNICATION Preoperative BRAF Mutation
More informationPapillary thyroid cancer accounts for approximately 90% Lymph Node Dissection in Papillary Thyroid Carcinoma
Lymph Node Dissection in Papillary Thyroid Carcinoma Tracy-Ann S. Moo, MD, and Thomas J. Fahey III, MD The management of papillary thyroid carcinoma continues to evolve. Although the debate over the extent
More informationOxford Centre for Head and Neck Oncology The Thyroid Gland and Thyroid Cancer Information for patients
Oxford University Hospitals NHS Trust Oxford Centre for Head and Neck Oncology The Thyroid Gland and Thyroid Cancer Information for patients What is the thyroid gland? The thyroid gland is an endocrine
More informationImage. 3.11.3 SW Review the anatomy of the EAC and how this plays a role in the spread of tumors.
Neoplasms of the Ear and Lateral Skull Base Image 3.11.1 SW What are the three most common neoplasms of the auricle? 3.11.2 SW What are the four most common neoplasms of the external auditory canal (EAC)
More informationCurrent Treatment of Papillary Thyroid Microcarcinoma
Advances in Surgery 46 (2012) 191 203 ADVANCES IN SURGERY Current Treatment of Papillary Thyroid Microcarcinoma Xiao-Min Yu, MD, PhD a, Ricardo Lloyd, MD, PhD b, Herbert Chen, MD c, * a Department of Surgery,
More informationThyroid Cancer A Multidisciplinary Approach
Thyroid Cancer A Multidisciplinary Approach Shuvendu Sen, MD, MS, FACP Associate Program Director, Internal Medicine Residency Program Director, Medical Education Raritan Bay Medical Center, Rutgers University
More informationPreventable reoperations for persistent and recurrent papillary thyroid carcinoma
Preventable reoperations for persistent and recurrent papillary thyroid carcinoma Maria A. Kouvaraki, MD, PhD, Jeffrey E. Lee, MD, Suzanne E. Shapiro, MS, Steven I. Sherman, MD, and Douglas B. Evans, MD,
More informationIlioinguinal dissection (removal of lymph nodes in the groin and pelvis)
Ilioinguinal dissection (removal of lymph nodes in the groin and pelvis) This sheet answers common questions about ilio-inguinal dissection. If you would like further information, or have any particular
More information13 Management of Cervical Lymph Nodes in Differentiated Thyroid Cancer
13 Management of Cervical Lymph Nodes in Differentiated Thyroid Cancer John C. Watkinson Introduction The majority of patients with differentiated thyroid cancer have papillary carcinoma and most are treated
More informationUnderstanding your pathology report
Understanding your pathology report 2 Contents Contents Introduction 3 What is a pathology report? 3 Waiting for your results 4 What s in a pathology report? 4 Information about your breast cancer 5 What
More informationCorporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid
Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_markers_in_fine_needle_aspirates_of_the_thyroid
More informationWell-differentiated Thyroid Carcinoma: Factors Predicting Recurrence and Survival
Singapore Med J 2002 Vol 43(9) : 457-462 O r i g i n a l A r t i c l e Well-differentiated Thyroid Carcinoma: Factors Predicting Recurrence and Survival L H Y Lim, K C Soo, Y K Chong, F Gao, G S Hong,
More informationShould All Papillary Thyroid Microcarcinomas Be Aggressively Treated? An Analysis of 18,445 Cases
PAPERS OF THE 131ST ASA ANNUAL MEETING Should All Papillary Thyroid Microcarcinomas Be Aggressively Treated? An Analysis of 18,445 Cases Xiao-Min Yu, MD, PhD, Yin Wan, MS, Rebecca S. Sippel, MD, FACS,
More informationKidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
More informationConflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.
Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates Jeffrey F. Krane, MD PhD Associate Professor of Pathology Harvard Medical School Chief, Head and Neck Pathology Service Associate Director,
More informationManagement Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
THYROID Volume 16, Number 2, 2006 American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Taskforce*
More informationRecommendations for cross-sectional imaging in cancer management, Second edition
www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who
More informationOBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
More informationObjectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
More informationBreast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.
Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are
More informationLymph Node Dissection for Penile Cancer
Lymph Node Dissection for Penile Cancer Exceptional healthcare, personally delivered Removal of Lymph Nodes Why are the Lymph Nodes so important when I have penile cancer? Lymph nodes are small bean shaped
More informationCurrent Status and Perspectives of Radiation Therapy for Breast Cancer
Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic
More informationValidation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach
Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Kerry C. Councilman, MD Assistant Professor University of Colorado Denver Goals: BRAF Mutation
More informationPrognostic and Predictive Factors in Oncology. Mustafa Benekli, M.D.
Prognostic and Predictive Factors in Oncology Mustafa Benekli, M.D. NCI Definitions ESMO Course -Essentials of Medical Oncology -Istanbul 2 Prognostic factor: NCI Definition A situation or condition, or
More informationPediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
More informationThyroid Surgery at Massachusetts General Hospital Frequently Asked Questions
Thyroid Surgery at Massachusetts General Hospital Frequently Asked Questions Q: What is the thyroid gland? A: The thyroid is a butterfly-shaped gland located in the front of the neck. It is one of the
More informationClinicopathological features of recurrent papillary thyroid cancer
Zhu et al. Diagnostic Pathology (2015) 10:96 DOI 10.1186/s13000-015-0346-5 RESEARCH Open Access Clinicopathological features of recurrent papillary thyroid cancer Jian Zhu 1, Xinli Wang 2, Xiaoxuan Zhang
More informationHosts. New Methods for Treating Colorectal Cancer
Hosts Anees Chagpar MD Associate Professor of Surgical Oncology Francine MD Professor of Medical Oncology New Methods for Treating Colorectal Cancer Guest Expert: Scott, MD Associate Professor in the Department
More informationRevised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
THYROID Volume 19, Number 11, 2009 ª Mary Ann Liebert, Inc. DOI: 10.1089=thy.2009.0110 ORIGINAL STUDIES, REVIEWS, AND SCHOLARLY DIALOG THYROID CANCER AND NODULES Revised American Thyroid Association Management
More informationCervical Cancer The Importance of Cervical Screening and Vaccination
Cervical Cancer The Importance of Cervical Screening and Vaccination Cancer Cells Cancer begins in cells, the building blocks that make up tissues. Tissues make up the organs of the body. Sometimes, this
More informationChallenges in gastric, appendiceal and rectal NETs Leuven, 29.11.2014
Challenges in gastric, appendiceal and rectal NETs Leuven, 29.11.2014 Prof. Dr. Chris Verslype, Leuven Prof. Dr. Aurel Perren, Bern Menue Challenges: 1. Gastric NET 2. Appendiceal NET 3. Rectal NET SEER,
More information0021-972X/97/$03.00/0 Vol. 82, No. 11 Journal of Clinical Endocrinology and Metabolism Copyright 1997 by The Endocrine Society
0021-972X/97/$03.00/0 Vol. 82, No. 11 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1997 by The Endocrine Society Pathological Tumor-Node-Metastasis (ptnm) Staging for Papillary
More informationOutline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
More informationRotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
More informationAACE/AAES MEDICAL/SURGICAL GUIDELINES FOR CLINICAL PRACTICE: MANAGEMENT OF THYROID CARCINOMA
AACE/AAES MEDICAL/SURGICAL GUIDELINES FOR CLINICAL PRACTICE: MANAGEMENT OF THYROID CARCINOMA Thyroid Carcinoma Task Force Co-Chairpersons Rhoda H. Cobin, MD, FACE Hossein Gharib, MD, FACP, FACE Committee
More informationSentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds
Sentinel Lymph Node Mapping for Endometrial Cancer Locke Uppendahl, MD Grand Rounds Endometrial Cancer Most common gynecologic malignancy in US estimated 52,630 new cases in 2014 estimated 8,590 deaths
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationThyroid Carcinoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 2.2014. NCCN.org. Continue
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 2.2014 NCCN.org Continue Version 2.2014, 08/12/2014 National Comprehensive Cancer Network, Inc. 2014, All rights reserved. The NCCN
More informationWhat s new in Endocrine Surgery?
What s new in Endocrine Surgery? THE COOL, THE CONTROVERSIAL AND THE CRAZY CORTNEY Y. LEE, M.D. ASSISTANT PROFESSOR OF SURGERY SECTION OF ENDOCRINE SURGERY Objectives Define endocrine surgery Review changes
More informationPost-PET Restaging Cancer Form National Oncologic PET Registry
Post-PET Restaging Cancer Form National Oncologic PET Registry Facility ID #: Registry Case Number: Patient Name: Your patient had a PET scan on: mm/dd/yyyy. The PET scan was done for restaging of (cancer
More informationOriginal Investigation
Research Original Investigation Lack of Association of BRAF Mutation With Negative Prognostic Indicators in Papillary Thyroid Carcinoma The University of California, San Francisco, Experience Christopher
More informationEuropean consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
European Journal of Endocrinology (2006) 154 787 803 ISSN 0804-4643 CONSENSUS STATEMENT European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
More informationUnderstanding Your Surgical Options For Breast Cancer
RADIATION THERAPY SYMPTOM MANAGEMENT CANCER INFORMATION Understanding Your Surgical Options For Breast Cancer In this booklet you will learn about: Role of surgery in breast cancer diagnosis and treatment
More informationATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA
Papillary carcinoma is the most common of thyroid malignancies and occurs in all age groups but particularly in women under 45 years of age. There is a high rate of cervical metastatic disease and yet
More informationBreast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.
Breast Cancer Introduction Cancer of the breast is the most common form of cancer that affects women but is no longer the leading cause of cancer deaths. About 1 out of 8 women are diagnosed with breast
More informationThere are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.
About Cancer Cancer is a disease where there is a disturbance in the normal pattern of cell replacement. The cells mutate and become abnormal or grow uncontrollably. Not all tumours are cancerous (i.e.
More informationORIGINAL ARTICLE. Results of Salvage Treatment of the Neck in Patients With Oral Cancer
Results of Salvage Treatment of the in Patients With Oral Cancer Luiz P. Kowalski, MD, PhD ORIGINAL ARTICLE Background: About 50% of the patients with neck recurrences after the treatment of oral squamous
More informationLoco-regional Recurrence
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer AGO AGO e. e. V. V. Loco-regional Recurrence Loco-regional Recurrence Version 2002: Brunnert / Simon Versions 2003 2012: Audretsch
More informationD. FREQUENTLY ASKED QUESTIONS
ACR BI-RADS ATLAS D. FREQUENTLY ASKED QUESTIONS 1. Under MQSA, is it necessary to include a numeric assessment code (i.e., 0, 1, 2, 3, 4, 5, or 6) in addition to the assessment category in all mammography
More informationNicole Kounalakis, MD
Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations
More informationOne out of every two men and one out of every three women will have some type of cancer at some point during their lifetime. 3
1. What is cancer? 2. What causes cancer?. What causes cancer? 3. Can cancer be prevented? The Facts One out of every two men and one out of every three women will have some type of cancer at some point
More informationThe Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.
Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD
More informationI Radiotherapy of Pediatric Thyroid Cancer
131 I Radiotherapy of Pediatric Thyroid Cancer Steven Waguespack, MD Associate Professor Dept of Endocrine Neoplasia and Hormonal Disorders Department of Pediatrics Patient Care University of Texas M.D.
More informationEndoscopic Therapy for Early Esophageal Cancer: EMR and ESD
Endoscopic Therapy for Early Esophageal Cancer: EMR and ESD AATS Toronto April 26, 2014 Lorenzo Ferri MD PhD David S. Mulder Chair in Surgery Associate Professor of Surgery and Oncology Disclosures Olympus
More informationTreating Melanoma S kin Cancer A Quick Guide
Treating Melanoma Skin Cancer A Quick Guide Contents This is a brief summary of the information on Treating melanoma skin cancer from our website. You will find more detailed information on the website.
More informationThyroid Cancer. What is thyroid cancer? The thyroid gland
Thyroid Cancer What is thyroid cancer? Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other areas of the body.
More informationExamples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.
CANCER SCREENING Dr. Tracy Sexton (updated July 2010) What is screening? Screening is the identification of asymptomatic disease or risk factors by history taking, physical examination, laboratory tests
More informationThe Relationship Between Lymphocytic Infiltration in the Thyroid Gland and Tumor Recurrence in Papillary Thyroid Carcinoma
Turkish Journal of Endocrinology and Metabolism, (1999) 3 : 113-117 ORIGINAL ARTICLE The Relationship Between Lymphocytic Infiltration in the Thyroid Gland and Tumor Recurrence in Papillary Thyroid Carcinoma
More informationUnderstanding Metastatic Disease
Supported by an unrestricted educational grant from Pfizer Understanding Metastatic Disease Metastatic disease or metastases are phrases that mean the same as Secondary cancer. This means that the cancer
More informationAdvances in management of thyroid cancer
Current Problems in Surgery 50 (2013) 241 289 Contents lists available at SciVerse ScienceDirect Current Problems in Surgery journal homepage: www.elsevier.com/locate/cpsurg Advances in management of thyroid
More informationAnaplastic Thyroid Cancer:
1 Anaplastic Thyroid Cancer: A Doctor s Perspective for Patients and Families Living with the Disease By Maria E. Cabanillas, M.D., F.A.C.E. Associate Professor and Faculty Director of Clinical Research
More informationReoperation for Recurrent/Persistent Well-Differentiated Thyroid Cancer
Reoperation for Recurrent/Persistent Well-Differentiated Thyroid Cancer Sara I. Pai, MD, PhD a,b, Ralph P. Tufano, MD a, * KEYWORDS Recurrent/persistent papillary thyroid cancer Well-differentiated thyroid
More informationMEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15
MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,
More informationBREAST CANCER PATHOLOGY
BREAST CANCER PATHOLOGY FACT SHEET Version 4, Aug 2013 This fact sheet was produced by Breast Cancer Network Australia with input from The Royal College of Pathologists of Australasia I m a nurse and know
More informationSurgical Staging of Endometrial Cancer
Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging
More informationPrimary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
More informationOverview of Gynaecologic Cancer
Overview of Gynaecologic Cancer Stuart Salfinger Gynaecologic Oncologist St John of God Hospital King Edward Memorial Hospital Cervical Cancer Cervical Cancer Risk HPV Smoking?OCP Cervical Cancer Symptoms
More informationTreating Thyroid Cancer using I-131 Maximum Tolerable Dose Method
Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method Christopher Martel, M.Sc., CHP Lisa Thornhill,, NRRPT, RT(NM) Boston University Medical Center Thyroid Carcinoma New cases and deaths in
More informationCancer of the Thyroid Explained
Cancer of the Thyroid Explained Patient Information Introduction This leaflet tells you about the condition known as thyroid cancer. We hope it will answer some of the questions that you or those who care
More informationThe 2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Cancer: An Author s Perspective
The 2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Cancer: An Author s Perspective AACE 2015 Hot Topics in Thyroid Practice May 13, 2015 Bryan R. Haugen, MD University
More informationPET/CT in Breast Cancer
PET/CT in Breast Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria Overview Introduction Locorregional
More information